A feasibility study on the development of Psorax35 as the first and only oral treatment for mild-to-moderate psoriasis with positive effects on co-morbidities

A feasibility study on the development of Psorax35 as the first and only oral treatment for mild-to-moderate psoriasis with positive effects on co-morbidities.

Ambitious plan to go global with psoriasis drug from natural marine products

Arctic Nutrition's PsoraxPlan project featured on the European Commission's CORDIS website.

Article: https://cordis.europa.eu/article/id/421517-ambitious-plan-to-go-global-with-psoriasis-drug-from-natural-marine-products